Plasma lipoprotein a values in familial ligand defective apo B 100 in a south European population;Estudio de los valores plasmáticos de Lp(a) en el defecto familiar de unión de la apo B 100 en una población mediterránea del sur de Europa

Anales de Medicina Interna

Volumn 21, Issue 7, 2004, Pages 322-325

  Ejarque, I ^a   Real, J T ^a   Ascaso, J F ^a   Chaves, F J ^a   Milian, E ^a   Priego, M A ^a   Carmena, Rafael ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Familial ligand defective apo B; Lipoprotein A, Lipid and lipoproteins

Indexed keywords

APOLIPOPROTEIN B100; LIPOPROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL DISEASE; FAMILIAL LIGAND DEFECTIVE APOLIPOPROTEIN B 100; FEMALE; GENE MUTATION; HETEROZYGOSITY; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN DEFICIENCY; MALE; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

ADULT; APOLIPOPROTEINS B; FEMALE; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; MUTATION; RECEPTORS, LIPOPROTEIN; SPAIN;

EID: 3543086167     PISSN: 02127199     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Myant NB. Familial defective apolipoprotein B-100: a review, including some comparison with familial hypercholesterolemia. Atherosclerosis 1993; 104: 1-18.
2. Rauh G, Séller C, Schuster H, Wolfgram G, Zöllnner N. Familial defective apolipoprotien B-100: a common cause of primary hyperlipemia. Clin Investigator 1995; 95: 1225-1234.
3. Pullinger CR, Hennessy LK, Chatterton JE, et al. Familial ligand-defective apolipoprotein B: identification of a new mutation that decreases LDL receptor binding affinity. J Clin Invest 1995; 95: 1225-1234.
4. Gaffney D, Reid JM, Cameron IM, et al. Independent mutations at codon 3500 of the apolipoprotein B gene are associated with hyperlipidaemia. Arterioscle Thromb Vasc Biol 1995; 15: 1025-1029.
5. Miserez AR, Keller U. Differences in the phenotypic characteristics of subjects with familial defective apolipoprotein B-100 and familial hypercholesterolemia. ATVB 1995; 15: 1719-1729.
6. Real JT, Chaves FJ, Ascaso JF, Armengod ME, Carmena R. Estudio del defecto familiar de la apo B-100 en sujetos con el diagnóstico clínico de hipercolesterolemia primaria: identificación de la primera familia afectada en España. Med Clin (Barc) 1999; 113: 15-17.
7. Castillo S, Tejedor D, Mozas P, Reyes G, Civeira F, Alonso R, Ros E, Pocovi M, Mata P. Atherosclerosis 2002; 165: 127-135.
8. Real JT, Chaves JF, Martín de Llano JJ, et al. Identificación y caracterización del primer homocigoto español con defecto familiar de unión de la apolipoproteína B. Med Clin (Barc) 2001; 116: 138-141.
9. Demant T, Seeberg K, Bedynek A, Seidel D. The metabolism of lipoprotein(a) and other apolipoprotein B-containing lipoproteins: a kinetic study in humans. Atherosclerosis 2001; 157: 325-39.
10. Pedro-Botet J, Rubies-Prat J. Lipoproteina (a) y aterotrombosis. Clin Invest Arterioscler 2003; 15: 258-260.
11. Perombelon YF, Gallagher JJ, Myant NB, Soutar AK, Knight BL. Lipoprotein(a) in subjects with familial defective apolipoprotein B100. Atherosclerosis 1992; 92: 203-12.
12. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 20: 470-5.
13. Burstein M, Scholnick HR, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 1970; 11: 583-95.
14. Havel RJ, Eder HJ, Bragdon JH. The distribution and chemical composition of centrifugally separated lipoproteins in human serum. Eur J Clin Invest 1995; 34: 1345-54.
15. Rosseneu M, Vercaemst R, Steinberg KK, Cooper GR. Some considerations of methodology and standarization of apolipoprotein B immunoassays. Clin Chem 1983; 29: 427-33.
16. Tilzer L, Thomas S, Moreno RF. Use of silica gel polymer for DNA extraction with organic solvents. Anal Biochem 1989; 183: 13-15.
17. García-García AB, Real JT, Puig O, et al. Molecular genetics of familial hipercolesterolemia in Spain: ten novel LDLR mutations and population analysis. Hum Mutat 2001; 454: 1-9.
18. Chaves FJ, Real JT, García-García AB, et al. Genetic diagnosis of familial hypercholesterolemia in a south European outbreed population: influence of low density lipoprotein (LDL) receptor gene mutations on treatment response to simvastatin in total, LDL and high density lipoprotein cholesterol. J Clin Endocrinol Metab 2001; 86: 4926-4932.
19. van der Hoek YY, Lingenhel A, Kraft HG, Defesche JC, Kastelein JJ, Utermann G. Sib-pair analysis detects elevated Lp(a) levels and large variation of Lp(a) concentration in subjects with familial defective ApoB. J Clin Invest 1997; 99: 2269-73
20. Seed M, Hopplicher F, Reaveley D, Mc Carthy S, Thompson G, Boerwinkle E, Uterman G. relation of serum lipoprotein (a) concentration and apolipoprotein a phenotype to coronary heart disease in patients with familial hypercholesterolemia. N Engl J Med 1990; 322: 1494-1499.
21. Kraft HG, Lingenhel A, Raal FJ, Hohenegger M, Utermann G. Lipoprotein(a) in homozygous familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 2000; 20: 522-8.
22. Rader DJ, Mann WA, Cain W, Kraft HG, Usher D, Zech La, et al. The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans. J Clin Invest 1995; 95: 1403-1408.
23. Armstrong VW, Walli AK, Seidel D. Isolation characterization and uptake in human fibroblasts of an apo(a) free lipoprotein obtained on reduction of lipoprotein(a). J Lipid Res 1985; 26: 1314-1318.
24. Thiery J, Armstrong VW, Schleef J, Creutzfeld C, Creutzfeld W, Seidel D. Serum lipoprotein Lp(a) concentrations are not influence by an HMG CoA reductase inhibitor. Klin Wochenschr 1988; 66: 462-466.
25. Carmena R, Lussier-Cacan S, Roy M, Minnich A, Lingenhel A, Kronenberg F, Davignon J. Lp(a) levels and atherosclerotic vascular disease in a sample of patients with familial hypercholesterolemia sharing the same gene defect. Arterioscler Thromb Vasc Biol 1996; 16: 129-36.
26. Real JT, Ascaso JF, Chaves FJ, Tenes S, Priego MA, Puig O, Armengod ME, Carmena R. Plasma Lp(a) values in familial hypercholesterolemia and its relation to coronary heart disease. Nutr Metab Cardiovasc Dis 1999; 941-4.